{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:22:41Z","timestamp":1793924561432,"version":"4.8.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2019BA015"],"award-info":[{"award-number":["ZR2019BA015"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejmech.2022.115026","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:27:07Z","timestamp":1671622027000},"page":"115026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens"],"prefix":"10.1016","volume":"247","author":[{"given":"Jingyue","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib1","article-title":"Considerations and caveats in combating ESKAPE pathogens against nosocomial infections","volume":"7","author":"Ma","year":"2020","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115026_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/14787210.2021.1858800","article-title":"Bacteriophages for ESKAPE: role in pathogenicity and measures of control","volume":"19","author":"Patil","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115026_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06310","article-title":"Antibacterial activity of medicinal plants against ESKAPE: an update","volume":"7","author":"Bhatia","year":"2021","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"10.1016\/j.ejmech.2022.115026_bib5","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.3390\/pathogens10101310","article-title":"Bacterial antibiotic resistance: the most critical pathogens","volume":"10","author":"Mancuso","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2022.115026_bib6","author":"World Health Organization"},{"key":"10.1016\/j.ejmech.2022.115026_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116674","article-title":"Recent insight into the biological activities and SAR of quinolone derivatives as multifunctional scaffold","volume":"59","author":"Sharma","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103291","article-title":"Recent advances in the synthetic and medicinal perspective of quinolones: a review","volume":"92","author":"Dhiman","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2022.115026_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/cbdd.14025","article-title":"Emerging quinoline- and quinolone-based antibiotics in the light of epidemics","volume":"100","author":"Kaur","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"issue":"10","key":"10.1016\/j.ejmech.2022.115026_bib10","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2022.115026_bib11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejmech.2018.08.095","article-title":"Recent developments of quinolone-based derivatives and their activities against Escherichia coli","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113741","article-title":"The antibacterial activity of fluoroquinolone derivatives: an update (2018-2021)","volume":"224","author":"Jia","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.115026_bib13","doi-asserted-by":"crossref","first-page":"e1455","DOI":"10.3390\/antibiotics10121455","article-title":"Mutational diversity in the quinolone resistance-determining regions of type-II topoisomerases of salmonella serovars","volume":"10","author":"Shaheen","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2022.115026_bib14","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.3389\/fmicb.2020.00271","article-title":"Global evolution of pathogenic bacteria with extensive use of fluoroquinolone agents","volume":"11","author":"Fuzi","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.115026_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","article-title":"Quinolone hybrids and their anti-cancer activities: an overview","volume":"165","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"30","key":"10.1016\/j.ejmech.2022.115026_bib16","doi-asserted-by":"crossref","first-page":"19470","DOI":"10.1039\/D2RA03281C","article-title":"Design and synthesis of hybrid compounds as novel drugs and medicines","volume":"12","author":"Alkhzem","year":"2022","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115026_bib17","doi-asserted-by":"crossref","first-page":"e1749","DOI":"10.3390\/pharmaceutics14081749","article-title":"Fluoroquinolones hybrid molecules as promising antibacterial agents in the fight against antibacterial resistance","volume":"14","author":"Lungu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ejmech.2022.115026_bib18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00706-018-2215-x","article-title":"Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules","volume":"149","author":"Fedorowicz","year":"2018","journal-title":"Monatsh. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115026_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/ijmr.IJMR_755_18","article-title":"Next-generation strategy for treating drug resistant bacteria: antibiotic hybrids","volume":"149","author":"Gupta","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ejmech.2022.115026_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","article-title":"4-Quinolone derivatives and their activities against Gram-positive pathogens","volume":"143","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2022.115026_bib21","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/acs.jmedchem.6b00485","article-title":"Development of a dual-acting antibacterial agent (TNP-2092) for the treatment of persistent bacterial infections","volume":"59","author":"Ma","year":"2016","journal-title":"J. Med. Chem."},{"issue":"50","key":"10.1016\/j.ejmech.2022.115026_bib22","doi-asserted-by":"crossref","first-page":"21127","DOI":"10.1021\/jacs.1c10200","article-title":"Prospects for antibacterial discovery and development","volume":"143","author":"Privalsky","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/1570163814666170911144036","article-title":"Review on synthetic chemistry and antibacterial importance of thiazole derivatives","volume":"15","author":"Kashyap","year":"2018","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.ejmech.2022.115026_bib24","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2147\/DDDT.S155958","article-title":"2-Amino-1,3,4-thiadiazole as a potential scaffold for promising antimicrobial agents","volume":"12","author":"Serban","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2022.115026_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112022","article-title":"N-Thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: design, synthesis, biological evaluation and target identification","volume":"188","author":"Xue","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129413","article-title":"Novel series of benzo[d]thiazolyl substituted-2-quinolone hybrids: design, synthesis, biological evaluation and in-silico insights","volume":"1227","author":"Bolakatti","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2022.115026_bib27","doi-asserted-by":"crossref","first-page":"e113340","DOI":"10.1016\/j.ejmech.2021.113340","article-title":"Membrane active 7-thiazoxime quinolones as novel DNA binding agents to decrease the genes expression and exert potent anti-methicillin-resistant Staphylococcus aureus activity","volume":"217","author":"Chen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2019.06.046","article-title":"A new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV","volume":"179","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib29","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00706-019-02478-4","article-title":"Synthesis, molecular docking, antimicrobial evaluation, and DNA cleavage assay of new thiadiazole\/oxadiazole ciprofoxacin derivatives","volume":"150","author":"Mohammed","year":"2019","journal-title":"Monatsh. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib30","first-page":"839","article-title":"Synthesis and evaluation of novel 1,3,4-thiadiazole-fluoroquinolone hybrids as antibacterial, antituberculosis, and anticancer agents","volume":"42","author":"Demirci","year":"2018","journal-title":"Turk. J. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115026_bib31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00044-012-0074-2","article-title":"Synthesis and antibacterial, antimycobacterial and docking studies of novel N-piperazinyl fluoroquinolones","volume":"22","author":"Agrawal","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.115026_bib32","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s11030-021-10302-7","article-title":"Thiazolidine-2,4-dione-linked ciprofoxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities","volume":"26","author":"Aziz","year":"2022","journal-title":"Mol. Divers."},{"issue":"22","key":"10.1016\/j.ejmech.2022.115026_bib33","doi-asserted-by":"crossref","first-page":"E202201007","DOI":"10.1002\/slct.202201007","article-title":"Quinolone-rhodanine hybrid compounds: synthesis and biological evaluation as anti-bacterial agents","volume":"7","author":"Cebeci","year":"2022","journal-title":"ChemistrySelect"},{"issue":"10","key":"10.1016\/j.ejmech.2022.115026_bib34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2174\/1570180815666171229150032","article-title":"Synthesis and antibacterial\/antitubercular\/antioxidant activities of compounds containing fluoroquinolone ring linked to a 4-thiazolidinone moiety","volume":"15","author":"Allaka","year":"2018","journal-title":"Lett. Drug Des. Discov."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115026_bib35","first-page":"3735","article-title":"Design, synthesis and comparative pharmacological assessment of novel fluoroquinolone derivatives","volume":"10","author":"Majalekar","year":"2019","journal-title":"Int. J. Pharma Sci. Res."},{"key":"10.1016\/j.ejmech.2022.115026_bib36","doi-asserted-by":"crossref","first-page":"e113442","DOI":"10.1016\/j.ejmech.2021.113442","article-title":"A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: structure-activity relationship studies","volume":"219","author":"Verm","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2022.115026_bib37","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1021\/acs.jmedchem.1c00480","article-title":"Current landscape and future perspective of oxazolidinone scaffolds containing antibacterial drugs","volume":"64","author":"Zhao","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202201565","article-title":"Synthesis, antibacterial evaluation and molecular docking studies of 1,3,4-oxadiazole-2(3H)-thione-norfloxacin hybrids as potent antibacterial agents","volume":"7","author":"Luo","year":"2022","journal-title":"ChemistrySelect"},{"issue":"5","key":"10.1016\/j.ejmech.2022.115026_bib39","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.3390\/ph14050399","article-title":"Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as dna gyrase and topoisomerase IV inhibitors","volume":"14","author":"Al-Wahaibi","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1570180814666170823163540","article-title":"Novel azole-functionalited flouroquinolone hybrids: design, conventional and microwave irradiated synthesis, evaluation as antibacterial and antioxidant agents","volume":"15","author":"Mentese","year":"2018","journal-title":"Lett. Drug Des. Discov."},{"issue":"46","key":"10.1016\/j.ejmech.2022.115026_bib41","doi-asserted-by":"crossref","first-page":"13209","DOI":"10.1002\/slct.202103078","article-title":"Design, synthesis and antibacterial studies of 1,3,4-oxadiazole-fluoroquinolone hybrids and their molecular docking studies","volume":"6","author":"Yang","year":"2021","journal-title":"ChemistrySelect"},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib42","first-page":"215","article-title":"In silico study and in vitro evaluation of novel synthesized quinolone derivatives having five-membered heterocyclic moieties","volume":"65","author":"Sheehan","year":"2022","journal-title":"Egypt. J. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115026_bib43","first-page":"1516","article-title":"Design, synthesis and pharmacological evaluation of new lomefloxacin derivatives having oxadiazole nucleus","volume":"11","author":"Saeed","year":"2019","journal-title":"J. Pharmaceut. Sci. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib44","first-page":"40","article-title":"Synthesis, molecular bioinformatics modelling, and antimicrobial evaluation of some novel oxadiazole fluoroquinolone derivatives","volume":"15","author":"Khan","year":"2022","journal-title":"Asian J. Pharmaceut. Clin. Res."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib45","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s11030-021-10287-3","article-title":"Novel heterocyclic 1,3,4-oxadiazole derivatives of fluoroquinolones as a potent antibacterial agent: synthesis and computational molecular modeling","volume":"26","author":"Allaka","year":"2022","journal-title":"Mol. Divers."},{"issue":"12","key":"10.1016\/j.ejmech.2022.115026_bib46","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1248\/cpb.c20-00525","article-title":"Design, synthesis and pharmacological evaluation of some C3 heterocyclic-substituted ciprofloxacin derivatives as chimeric antitubercular agents","volume":"68","author":"Niveditha","year":"2020","journal-title":"Chem. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.ejmech.2022.115026_bib47","doi-asserted-by":"crossref","DOI":"10.2174\/1570163817666201106143557","article-title":"Design, synthesis and biological evaluation of novel heterocyclic fluoro-quinolone citrate conjugates as potential inhibitors of Topoisomerase IV: a computational molecular modeling study","volume":"18","author":"Allaka","year":"2021","journal-title":"Curr. Drug Discov. Technol."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115026_bib48","doi-asserted-by":"crossref","first-page":"e1641","DOI":"10.3390\/molecules24081641","article-title":"Synthesis, antibacterial activities, mode of action and acute toxicity studies of new oxazolidinone-fluoroquinolone hybrids","volume":"24","author":"Liu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115026_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112686","article-title":"1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"206","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1871522218666180525100850","article-title":"Tetrazoles: synthesis and biological activity","volume":"18","author":"Kaushik","year":"2018","journal-title":"Immunol. Endocr. Metab. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib51","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ejmech.2017.10.042","article-title":"Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates","volume":"143","author":"Faidallah","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115026_bib52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/10799893.2021.1988971","article-title":"DFT based QSAR study on quinolone-triazole derivatives as antibacterial agents","volume":"42","author":"Ghasedi","year":"2022","journal-title":"J. Recept. Signal Transduction"},{"issue":"9","key":"10.1016\/j.ejmech.2022.115026_bib53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1021\/acscombsci.0c00060","article-title":"Synthesis of bioactive complex small molecule-ciprofloxacin conjugates and evaluation of their antibacterial activity","volume":"22","author":"Upadhyay","year":"2020","journal-title":"ACS Comb. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib54","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1021\/acsomega.1c05303","article-title":"Ciprofloxacin-tethered 1,2,3-triazole conjugates: new quinolone family compounds to upgrade our antiquated approach against bacterial infections","volume":"7","author":"Agarwal","year":"2022","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib55","first-page":"e2","article-title":"The search for new antibacterial agents among 1,2,3-triazole functionalized ciprofloxacin and norfloxacin hybrids: synthesis, docking studies, and biological activity evaluation","volume":"90","author":"Filimonova","year":"2022","journal-title":"Sci. Pharm."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115026_bib56","doi-asserted-by":"crossref","first-page":"E202100714","DOI":"10.1002\/cmdc.202100714","article-title":"Design, synthesis, in vitro and in silico characterization of 2-quinolone-L-alaninate-1,2,3-triazoles as antimicrobial agents","volume":"17","author":"Moussaoui","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.115026_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102952","article-title":"Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity","volume":"88","author":"Mohammed","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2022.115026_bib58","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12272-018-1025-3","article-title":"Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives","volume":"41","author":"Popio\u0142ek","year":"2018","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"10","key":"10.1016\/j.ejmech.2022.115026_bib59","doi-asserted-by":"crossref","first-page":"E1800261","DOI":"10.1002\/cbdv.201800261","article-title":"Design, synthesis and antibacterial evaluation of 1-[(1R,2S)-2-fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione hybrids","volume":"15","author":"Gao","year":"2018","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.33224\/rrch.2019.64.1.10","article-title":"Design, synthesis and antibacterial evaluation of 1-[(1R,2S)-2-fluorocyclopropyl] ciprofloxacin-(4-methyl-3-aryl)-1,2,4-triazole-5(4H)-thione hybrids","volume":"64","author":"Geng","year":"2019","journal-title":"Rev. Roum. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105270","article-title":"Synthesis, molecular docking, and evaluation of antibacterial activity of 1,2,4-triazole-norfloxacin hybrids","volume":"115","author":"Yang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib62","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bioorg.2019.01.009","article-title":"Piperazine-azole-fluoroquinolone hybrids: conventional and microwave irradiated synthesis, biological activity screening and molecular docking studies","volume":"85","author":"Mermer","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.115026_bib63","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/jhet.3336","article-title":"Microwave-assisted synthesis, antioxidant, and antimicrobial evaluation of piperazine-azole-fluoroquinolone based 1,2,4-triazole derivatives","volume":"55","author":"Ozdemir","year":"2018","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib64","article-title":"An efficient microwave-assisted synthesis of novel quinolone-triazole and conazole-triazole hybrid derivatives as antimicrobial and anticancer agents","author":"Cebeci","year":"2022","journal-title":"J. Heterocycl. Chem."},{"issue":"35","key":"10.1016\/j.ejmech.2022.115026_bib65","doi-asserted-by":"crossref","first-page":"9467","DOI":"10.1002\/slct.202101840","article-title":"Synthesis and antimicrobial, antiproliferative evaluation of novel quinolone and conazole analogues via conventional and microwave techniques","volume":"6","author":"Ceylan","year":"2021","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11030-017-9795-y","article-title":"Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity","volume":"22","author":"Dileep","year":"2018","journal-title":"Mol. Divers."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115026_bib67","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00044-010-9472-5","article-title":"Biological importance of imidazole nucleus in the new millennium","volume":"20","author":"Narasimhan","year":"2011","journal-title":"Med. Chem. Res."},{"issue":"11","key":"10.1016\/j.ejmech.2022.115026_bib68","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2174\/1389557514666141029225524","article-title":"Antimicrobial activity and mechanism of action of new N-heteroaryl-1H-(benz)imidazoles","volume":"14","author":"Pinto","year":"2014","journal-title":"Mini-Rev. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2022.115026_bib69","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cmdc.201700739","article-title":"Discovery of benzimidazole-quinolone hybrids as new cleaving agents toward drug-resistant Pseudomonas aeruginosa DNA","volume":"13","author":"Wang","year":"2018","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bmc.2018.11.035","article-title":"Design, synthesis, biological evaluation, structure-activity relationship, and toxicity of clinafloxacin-azole conjugates as novel antitubercular agents","volume":"27","author":"Liu","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib71","doi-asserted-by":"crossref","first-page":"133","DOI":"10.31351\/vol30iss1pp133-143","article-title":"Synthesis of mutual prodrugs of secnidazole and ciprofloxacin and study their physicochemical properties","volume":"30","author":"Khalid","year":"2021","journal-title":"Iraqi J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2022.115026_bib72","doi-asserted-by":"crossref","first-page":"e1069","DOI":"10.3390\/molecules27031069","article-title":"Preliminary studies of antimicrobial activity of new synthesized hybrids of 2-thiohydantoin and 2-quinolone derivatives activated with blue light","volume":"27","author":"Kania","year":"2022","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.ejmech.2022.115026_bib73","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/cmdc.202000378","article-title":"Recent development of pyrimidine-containing antimicrobial agents","volume":"15","author":"Zhuang","year":"2020","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.ejmech.2022.115026_bib74","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jhet.4382","article-title":"Medicinal perspective of quinazolinone derivatives: recent developments and structure-activity relationship studies","volume":"69","author":"Wahan","year":"2022","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128885","article-title":"Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents","volume":"73","author":"Tan","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.115026_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104176","article-title":"Design and synthesis of novel desfluoroquinolone-aminopyrimidine hybrids as potent anti-MRSA agents with low hERG activity","volume":"103","author":"Song","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"31","key":"10.1016\/j.ejmech.2022.115026_bib77","doi-asserted-by":"crossref","first-page":"8930","DOI":"10.1002\/slct.201901924","article-title":"Synthesis and antibacterial evaluation of new pyrimidyl N-ciprofloxacin derivatives","volume":"4","author":"Mokaber-Esfahani","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2022.115026_bib78","first-page":"1065","article-title":"Synthesis and antibacterial activity of 1,3-dione derivatives of 1-cyclopropyl-7-[4-(2,6-dimethyl\/dimethoxypyrimidin-2-yl-diazenyl)-piperzin-1-yl]-6-5-oxo-1,4-dihydroquinolone-3-carboxylic acid","volume":"57B","author":"Yadav","year":"2018","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib79","article-title":"Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: design, synthesis, and biological evaluation","volume":"1271","author":"Abdel-Aziz","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2022.115026_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104658","article-title":"Antibiotic resistance and drug modification: synthesis, characterization and bioactivity of newly modified potent ciprofloxacin derivatives","volume":"108","author":"Alsughayer","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117004","article-title":"New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus","volume":"73","author":"Samir","year":"2022","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115026_bib82","first-page":"2126","article-title":"Synthesis and biological activities of three-molecule conjugates with para-aminosalicylic acid as parent nucleus","volume":"57","author":"Ren","year":"2022","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ejmech.2022.115026_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.963442","article-title":"Synthesis and antibacterial activity evaluation of N (7) position-modified balofloxacins","volume":"10","author":"Hong","year":"2022","journal-title":"Front. Chem."},{"issue":"34","key":"10.1016\/j.ejmech.2022.115026_bib84","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.1002\/slct.201901866","article-title":"One-pot synthesis of 2-amino-6-(1,2-dihydro-4-hydroxy-2-oxoquinolin-3-yl)-4-arylpyridine-3-carbonitriles catalysed by NbCl5 and their in vitro antimicrobial studies","volume":"4","author":"Krishna","year":"2019","journal-title":"ChemistrySelect"},{"issue":"2","key":"10.1016\/j.ejmech.2022.115026_bib85","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40199-020-00373-6","article-title":"Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety","volume":"28","author":"Norouzbahari","year":"2020","journal-title":"DARU J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib86","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1080\/14756366.2022.2084088","article-title":"Discovery of N-quinazolinone-4-hydroxy-2-quinolone-3-carboxamides as DNA gyrase B-targeted antibacterial agents","volume":"37","author":"Han","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115026_bib87","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","article-title":"Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions","volume":"13","author":"Ovung","year":"2021","journal-title":"Biophy. Rev."},{"key":"10.1016\/j.ejmech.2022.115026_bib88","article-title":"Antibacterial activities of sulfonyl or sulfonamide containing heterocyclic derivatives and its structure-activity relationships (SAR) studies: a critical review","volume":"105","author":"Verma","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib89","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejmech.2019.01.062","article-title":"Design, synthesis and anti-bacterial studies of piperazine derivatives against drug resistant bacteria","volume":"166","author":"Tahir","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102965","article-title":"Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents","volume":"88","author":"T\u00fcre","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100397","article-title":"Synthesis of new 3-substituted quinolone derivatives with benzene sulfonamide group using hydrazine linker with their docking and antibacterial studies in vitro","volume":"4","author":"Saxena","year":"2022","journal-title":"Results Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115026_bib92","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.5958\/0974-360X.2018.00570.X","article-title":"Synthesis, molecular docking and antibacterial evalution of some novel N-4 piperzinyl derivatives of 8-methoxy grepafloxacin","volume":"11","author":"Kumar","year":"2018","journal-title":"Res. J. Pharm. Technol."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000291","article-title":"Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety","volume":"354","author":"Bazine","year":"2021","journal-title":"Arch. Pharm."},{"issue":"22","key":"10.1016\/j.ejmech.2022.115026_bib94","article-title":"Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors","volume":"28","author":"Amada","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2022.115026_bib95","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1021\/acsinfecdis.0c00223","article-title":"A semisynthetic kanglemycin shows in vivo efficacy against high-burden rifampicin resistant pathogens","volume":"6","author":"Brady","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115026_bib96","doi-asserted-by":"crossref","first-page":"e111662","DOI":"10.1016\/j.ejmech.2019.111662","article-title":"14- and 15-Membered lactone macrolides and their analogues and hybrids: structure, molecular mechanism of action and biological activity","volume":"182","author":"Janas","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128484","article-title":"Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics","volume":"57","author":"Peek","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"15","key":"10.1016\/j.ejmech.2022.115026_bib98","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/jacs.8b01042","article-title":"Esterase-catalyzed siderophore hydrolysis activates an enterobactin-ciprofloxacin conjugate and confers targeted antibacterial activity","volume":"140","author":"Neumann","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.115026_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.02.073","article-title":"Design, synthesis and structure-activity relationships of novel macrolones: hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens","volume":"169","author":"Ma","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejmech.2019.03.037","article-title":"Synthesis and structure-bactericidal activity relationships of non-ketolides: 9-Oxime clarithromycin 11,12-cyclic carbonate featured with three-to eight-atom-length spacers at 3-OH","volume":"171","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128761","article-title":"Design and synthesis of novel macrolones bridged with linkers from 11,12-positions of macrolides","volume":"68","author":"Liu","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.115026_bib102","doi-asserted-by":"crossref","first-page":"e112222","DOI":"10.1016\/j.ejmech.2020.112222","article-title":"Design, synthesis and structure-activity relationships of novel 15-membered macrolides: quinolone\/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides","volume":"193","author":"Fan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib103","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1568026621666211116090456","article-title":"The antibacterial activity of isatin hybrids","volume":"22","author":"Liu","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133634","article-title":"A review: structure-activity relationship and antibacterial activities of quinoline based hybrids","volume":"1268","author":"Patel","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2022.115026_bib105","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ejmech.2018.07.025","article-title":"Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids","volume":"156","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2022.115026_bib106","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/jhet.3279","article-title":"Design, synthesis, and antibacterial evaluation of propylene-tethered 8-methoxyl ciprofloxacin-isatin hybrids","volume":"55","author":"Guo","year":"2018","journal-title":"J. Heterocycl. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115026_bib107","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/jhet.3226","article-title":"Design, synthesis, and in vitro antibacterial activities of propylene-tethered gatifloxacin-isatin hybrids","volume":"55","author":"Guo","year":"2018","journal-title":"J. Heterocycl. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib108","doi-asserted-by":"crossref","first-page":"239","DOI":"10.33224\/rrch.2020.65.3.03","article-title":"Gatifloxacin-1,2,3-triazole-isatin hybrids tethered through methylene and acetyl and their antibacterial activities","volume":"65","author":"Guo","year":"2020","journal-title":"Rev. Roum. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103162","article-title":"Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1,2,3-triazole-isatin hybrids","volume":"91","author":"Gao","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib110","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejmech.2019.06.071","article-title":"Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents","volume":"179","author":"Ciura","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.115026_bib111","article-title":"Modified fluoroquinolones as antimicrobial compounds targeting Chlamydia trachomatis","volume":"23","author":"Adhel","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib112","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00044-021-02815-5","article-title":"Synthesis and potential antimicrobial activity of novel \u03b1-aminophosphonates derivatives bearing substituted quinoline or quinolone and thiazole moieties","volume":"31","author":"Boukhari","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.115026_bib113","article-title":"Synthesis and molecular docking of new N4-piperazinyl ciprofoxacin hybrids as antimicrobial DNA gyrase inhibitors","author":"Mohammed","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2022.115026_bib114","article-title":"Synthesis and in vitro antibacterial activity of N-acylarylhydrazone-ciprofloxacin hybrids as novel fluoroquinolone derivatives","volume":"1262","author":"Luo","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2022.115026_bib115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2018.03.026","article-title":"Novel ciprofloxacin hybrids using biology-oriented drug synthesis (BIODS) approach: anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity","volume":"150","author":"Kassab","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib116","first-page":"E126562","article-title":"Design, synthesis, docking study, and biological evaluation of 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbohydrazide derivatives as anti-HIV-1 and antibacterial agents","volume":"21","author":"Abdollahi","year":"2022","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib117","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s43440-020-00193-0","article-title":"Synthesis, antitumor, antibacterial and urease inhibitory evaluation of new piperazinyl N-4 carbamoyl functionalized ciprofloxacin derivatives","volume":"73","author":"Abdel-Aal","year":"2021","journal-title":"Pharmacol. Rep."},{"issue":"11","key":"10.1016\/j.ejmech.2022.115026_bib118","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/10426507.2019.1618298","article-title":"Synthesis, antibacterial activity and docking studies of substituted quinolone thiosemicarbazones","volume":"194","author":"Govender","year":"2019","journal-title":"Phosphorus, Sulfur Silicon Relat. Elem."},{"key":"10.1016\/j.ejmech.2022.115026_bib119","article-title":"Study of antimicrobial effect of a new fluoroquinolone derivative against pathogenic bacteria in planktonic form and biofilm","author":"Taghavi","year":"2022","journal-title":"Proc. Natl. Acad. Sci. India B Biol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000180","article-title":"Synthesis and antimicrobial evaluation of new nitric oxide-donating fluoroquinolone\/oxime hybrids","volume":"354","author":"Aziz","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2022.115026_bib121","doi-asserted-by":"crossref","first-page":"e1556","DOI":"10.3389\/fmicb.2019.01556","article-title":"Repurposed antimicrobial combination therapy: tobramycin-ciprofloxacin hybrid augments activity of the anticancer drug mitomycin C against multidrug-resistant Gram-negative bacteria","volume":"10","author":"Domalaon","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.115026_bib122","doi-asserted-by":"crossref","first-page":"e112513","DOI":"10.1016\/j.ejmech.2020.112513","article-title":"Design, synthesis and antimicrobial evaluation of novel glycosylated-fluoroquinolones derivative","volume":"202","author":"Mohammed","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib123","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ddr.21508","article-title":"Design, synthesis, and biological evaluation of 1,8-naphthyridine glucosamine conjugates as antimicrobial agents","volume":"80","author":"Mohammed","year":"2019","journal-title":"Drug Dev. Res."},{"issue":"9","key":"10.1016\/j.ejmech.2022.115026_bib124","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1021\/acs.jmedchem.8b01923","article-title":"Exploitation of antibiotic resistance as a novel drug target: development of a \u03b2-lactamase-activated antibacterial prodrug","volume":"62","author":"Evans","year":"2019","journal-title":"J. Med. Chem."},{"issue":"31","key":"10.1016\/j.ejmech.2022.115026_bib125","doi-asserted-by":"crossref","first-page":"13308","DOI":"10.1039\/D0NJ00657B","article-title":"The synthesis and biological evaluation of virtually designed fluoroquinolone analogs against fluoroquinolone-resistant: Escherichia coli intended for UTI treatment","volume":"44","author":"Balasubramaniyan","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib126","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.3390\/scipharm88040057","article-title":"Novel amino acid derivatives of quinolines as potential antibacterial and fluorophore agents","volume":"88","author":"Moussaoui","year":"2020","journal-title":"Sci. Pharm."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115026_bib127","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cbdd.13638","article-title":"Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone-dichloroacetic acid hybrids","volume":"95","author":"Seliem","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1573406415666190904143852","article-title":"Fluoroquinolone-3-carboxamide amino acid conjugates: synthesis, antibacterial properties and molecular modeling studies","volume":"17","author":"Bokhtia","year":"2021","journal-title":"Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2022.115026_bib129","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1021\/acs.molpharmaceut.1c00430","article-title":"Conjugates of ciprofloxacin and amphiphilic block copoly(2-alkyl-2-oxazolines)s overcome efflux pumps and are active against CIP-resistant bacteria","volume":"18","author":"Romanovska","year":"2021","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115026_bib130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1039\/C9MD00051H","article-title":"Polybasic peptide-levofloxacin conjugates potentiate fluoroquinolones and other classes of antibiotics against multidrug-resistant Gram-negative bacteria","volume":"10","author":"Berry","year":"2019","journal-title":"MedChemComm"},{"issue":"13","key":"10.1016\/j.ejmech.2022.115026_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134696","article-title":"Conjugates of ciprofloxacin and levofloxacin with cell-penetrating peptide exhibit antifungal activity and mammalian cytotoxicity","volume":"21","author":"Ptaszy\u0144ska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib132","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cmdc.201900607","article-title":"Dual Escherichia coli DNA gyrase A and B inhibitors with antibacterial activity","volume":"15","author":"Fois","year":"2020","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.ejmech.2022.115026_bib133","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.3390\/pharmaceutics13010006","article-title":"Hybrid inhibitors of DNA gyrase A and B: design, synthesis and evaluation","volume":"13","author":"Durcik","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejmech.2022.115026_bib134","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.31925\/farmacia.2018.6.19","article-title":"Design, synthesis, molecular docking, and antibacterial activity evaluation of some novel norfloxacin analogues","volume":"66","author":"Oniga","year":"2018","journal-title":"FARMACIA"},{"issue":"8","key":"10.1016\/j.ejmech.2022.115026_bib135","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1134\/S1070363220080265","article-title":"Novel N-4-piperazinyl ciprofloxacin-ester hybrids: synthesis, biological evaluation, and molecular docking studies","volume":"90","author":"Mahdavi","year":"2020","journal-title":"Russ. J. Gen. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2022.115026_bib136","doi-asserted-by":"crossref","first-page":"11923","DOI":"10.1021\/acsomega.9b03910","article-title":"N1-Benzofused modification of fluoroquinolones reduces activity against Gram-negative bacteria","volume":"5","author":"Laws","year":"2020","journal-title":"ACS Omega"},{"issue":"10","key":"10.1016\/j.ejmech.2022.115026_bib137","doi-asserted-by":"crossref","first-page":"E1800273","DOI":"10.1002\/cbdv.201800273","article-title":"Biology-oriented drug synthesis (BIODS) approach towards synthesis of ciprofloxacin-dithiocarbamate hybrids and their antibacterial potential both in vitro and in silico","volume":"15","author":"Esfahani","year":"2018","journal-title":"Chem. Biodivers."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115026_bib138","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11172-022-3441-2","article-title":"Synthesis and antibacterial activity of fluoroquinolones with sterically hindered phenolic moieties","volume":"71","author":"Bukharov","year":"2022","journal-title":"Russ. Chem. Bull."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115026_bib139","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00044-022-02869-z","article-title":"Synthesis, antibacterial evaluation and in silico study of DOTA-fluoroquinolone derivatives","volume":"31","author":"Li","year":"2022","journal-title":"Med. Chem. Res."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115026_bib140","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/acsmedchemlett.2c00185","article-title":"N-Alkyl-2-quinolonopyrones demonstrate antimicrobial activity against ESKAPE pathogens including Staphylococcus aureus","volume":"13","author":"Moynihan","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115026_bib141","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jhet.4424","article-title":"Synthesis and biological evaluation of some novel hetroaryl quinolinone derivatives","volume":"59","author":"Abd El-Ghani","year":"2022","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2022.115026_bib142","article-title":"Binary and ternary copper(II) complexes with 6-ethyl-4-hydroxy-2,5-dioxo-5,6-dihydro-2H-pyrano[3,2-c]quinoline-3-carboxaldehyde: synthesis, spectral, thermal, molecular modeling, antimicrobial and antitumor studies","volume":"1226","author":"Adly","year":"2021","journal-title":"J. Mol. Struct."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200928X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200928X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:49:34Z","timestamp":1759330174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342200928X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":142,"alternative-id":["S022352342200928X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115026","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115026"}}